Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong · Delayed Price · Currency is HKD 5.36
-0.07 (-1.20%)
Nov 11, 2026, 4:08 PM HKT
HKG:0719 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,195 | 1,397 | 1,245 | 918.33 | 1,159 | 744.66 |
Cash & Short-Term Investments | 1,195 | 1,397 | 1,245 | 918.33 | 1,159 | 744.66 |
Cash Growth | -3.21% | 12.18% | 35.57% | -20.75% | 55.61% | -12.98% |
Accounts Receivable | 1,189 | 1,209 | 1,120 | 949.16 | 970.63 | 870.46 |
Other Receivables | 11.79 | 3 | 9.5 | 9.34 | 12.65 | 17.42 |
Receivables | 1,201 | 1,212 | 1,129 | 958.5 | 983.28 | 887.87 |
Inventory | 1,445 | 1,318 | 1,273 | 1,313 | 1,212 | 1,028 |
Prepaid Expenses | - | 0.02 | 0.03 | 3.41 | - | - |
Other Current Assets | 140.96 | 106.79 | 79.78 | 121.1 | 102.95 | 93.88 |
Total Current Assets | 3,982 | 4,033 | 3,727 | 3,314 | 3,457 | 2,754 |
Property, Plant & Equipment | 3,919 | 4,152 | 4,296 | 4,061 | 4,000 | 3,766 |
Long-Term Investments | 287.64 | 338.27 | 306.42 | 241.37 | 239.18 | 260.2 |
Other Intangible Assets | 523.04 | 577.4 | 565.04 | 494.94 | 474.11 | 466.45 |
Long-Term Deferred Tax Assets | 18.07 | 21.19 | 24.92 | 23.48 | 15.62 | 15.17 |
Long-Term Deferred Charges | 30.82 | 15.76 | 9.99 | 14.46 | 8.61 | 10.54 |
Other Long-Term Assets | 47.23 | 47.82 | 90.75 | 136.77 | 69.85 | 59.99 |
Total Assets | 8,807 | 9,186 | 9,020 | 8,286 | 8,265 | 7,332 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,578 | 1,311 | 1,159 | 1,178 | 1,090 | 1,066 |
Accrued Expenses | 23.26 | 76.78 | 88.86 | 203.11 | 159.43 | 122.35 |
Short-Term Debt | 270.18 | 433.64 | 580.16 | 283.96 | 118.02 | 269.46 |
Current Portion of Long-Term Debt | 331.73 | 351.21 | 312.26 | 271.97 | 714.77 | 421.03 |
Current Portion of Leases | - | 0.94 | 1.4 | 1.78 | 2.69 | 2.8 |
Current Income Taxes Payable | 35.86 | 11.55 | 6.69 | 5.03 | 7.99 | 12.2 |
Current Unearned Revenue | 142.48 | 149.3 | 96.84 | 149.14 | 593.26 | 100.4 |
Other Current Liabilities | 25.93 | 476.66 | 550.72 | 393.16 | 472.23 | 507.26 |
Total Current Liabilities | 2,407 | 2,811 | 2,796 | 2,486 | 3,158 | 2,502 |
Long-Term Debt | 623 | 695.32 | 771.54 | 799.4 | 545.66 | 946.2 |
Long-Term Leases | 1.06 | 0.74 | 1.11 | 1.58 | 2.72 | 6.77 |
Long-Term Unearned Revenue | 55.68 | 68.97 | 83.25 | 100.67 | 118.37 | 133.97 |
Long-Term Deferred Tax Liabilities | 108.51 | 125.67 | 122.53 | 99.21 | 66.44 | 65.61 |
Other Long-Term Liabilities | 28.06 | 28.06 | 28.06 | 23.56 | 23.56 | 26.46 |
Total Liabilities | 3,224 | 3,730 | 3,802 | 3,510 | 3,915 | 3,681 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 696.68 | 689.78 | 682.41 | 674.68 | 669.63 | 627.37 |
Additional Paid-In Capital | 1,277 | 1,205 | 1,145 | 1,055 | 998.14 | 677.94 |
Retained Earnings | 3,197 | 3,106 | 2,989 | 2,706 | 2,345 | 2,034 |
Comprehensive Income & Other | 168.81 | 208.12 | 175.86 | 117.01 | 113.68 | 128.37 |
Total Common Equity | 5,339 | 5,209 | 4,992 | 4,553 | 4,126 | 3,468 |
Minority Interest | 245.09 | 246.97 | 225.91 | 222.65 | 223.29 | 183.2 |
Shareholders' Equity | 5,584 | 5,456 | 5,218 | 4,776 | 4,350 | 3,651 |
Total Liabilities & Equity | 8,807 | 9,186 | 9,020 | 8,286 | 8,265 | 7,332 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 1,226 | 1,482 | 1,666 | 1,359 | 1,384 | 1,646 |
Net Cash (Debt) | -31.12 | -85.2 | -421.45 | -440.36 | -225.11 | -901.58 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.04 | -0.12 | -0.61 | -0.64 | -0.34 | -1.44 |
Filing Date Shares Outstanding | 696.68 | 696.68 | 689.78 | 682.41 | 669.63 | 627.37 |
Total Common Shares Outstanding | 696.68 | 689.78 | 682.41 | 674.68 | 669.63 | 627.37 |
Working Capital | 1,574 | 1,222 | 931.23 | 828.33 | 298.47 | 252.08 |
Book Value Per Share | 7.66 | 7.55 | 7.31 | 6.75 | 6.16 | 5.53 |
Tangible Book Value | 4,816 | 4,631 | 4,427 | 4,058 | 3,652 | 3,001 |
Tangible Book Value Per Share | 6.91 | 6.71 | 6.49 | 6.01 | 5.45 | 4.78 |
Buildings | - | 2,642 | 2,411 | 2,271 | 2,244 | 2,078 |
Machinery | - | 5,647 | 5,128 | 4,703 | 4,468 | 4,011 |
Construction In Progress | - | 366.17 | 781.1 | 730.55 | 545.89 | 562.96 |